Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia

British Journal of Haematology

Volumn 153, Issue 6, 2011, Pages 764-772

  Li, Jianping ^a,b   Zhao, Qinjun ^a   Xing, Wen ^a   Feng, Jianming ^b   Wu, Hao ^a   Li, Huiyuan ^a   Ge, Meili ^a   Tian, Kun ^a   Li, Xingxin ^a   Zhou, Jianfeng ^a   Liu, Bin ^a   Zhang, Lei ^a   Zheng, Yizhou ^a   Han, Zhong C ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b Qinghai People's Hospital   (China)

Author keywords

Aplastic anaemia; Interferon ; Interleukin 27; Tumour necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; ANEMIA, APLASTIC; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; MALE; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957564919     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08431.x     Document Type: Article

References (47)

1. Apetoh, L., Quintana, F.J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E.J., Sherr, D.H., Weiner, H.L. & Kuchroo, V.K. (2010) The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nature Immunology, 11, 854-861.
2. Batten, M. & Ghilardi, N. (2007) The biology and therapeutic potential of interleukin 27. Journal of Molecular Medicine, 85, 661-672.
3. Bellone, G. & Trinchieri, G. (1994) Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. Journal of Immunology, 153, 930-937.
4. Brodsky, R.A. & Jones, R.J. (2005) Aplastic anaemia. Lancet, 365, 1647-1656.
5. Camitta, B.M., Thomas, E.D., Nathan, D.G., Gale, R.P., Kopecky, K.J., Rappeport, J.M., Santos, G., Gordon-Smith, E.C. & Storb, R. (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood, 53, 504-514.
6. Cao, Y., Doodes, P.D., Glant, T.T. & Finnegan, A. (2008) IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. Journal of Immunology, 180, 922-930.
7. Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M.H., Gurney, A., Grewal, I.S. & de Sauvage, F.J. (2000) Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature, 407, 916-920.
8. Chiyo, M., Shimozato, O., Yu, L., Kawamura, K., Iizasa, T., Fujisawa, T. & Tagawa, M. (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. International Journal of Cancer, 115, 437-442.
9. Dubey, S., Shukla, P. & Nityanand, S. (2005) Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Annals of Hematology, 84, 572-577.
10. Dufour, C., Corcione, A., Svahn, J., Haupt, R., Battilana, N. & Pistoia, V. (2001) Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. British Journal Haematology, 115, 1023-1031.
11. Dybedal, I., Larsen, S. & Jacobsen, S.E. (1995) IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor. Journal of Immunology, 154, 4950-4955.
12. Eng, V.M., Car, B.D., Schnyder, B., Lorenz, M., Lugli, S., Aguet, M., Anderson, T.D., Ryffel, B. & Quesniaux, V.F. (1995) The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo. Journal of Experimental Medicine, 181, 1893-1898.
13. Feng, X.M., Chen, X.L., Liu, N., Chen, Z., Zhou, Y.L., Han, Z.B., Zhang, L. & Han, Z.C. (2007) Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Human Immunology, 68, 965-972.
14. Gascon, P., Zoumbos, N.C., Scala, G., Djeu, J.Y., Moore, J.G. & Young, N.S. (1985) Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood, 65, 407-413.
15. Gee, K., Guzzo, C., Che Mat, N.F., Ma, W. & Kumar, A. (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflammation and Allergy Drug Targets, 8, 40-52.
16. Gu, Y., Hu, X., Liu, C., Qv, X. & Xu, C. (2008) Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. British Journal Haematology, 142, 109-114.
17. Gu, Y., Zhang, J., Peng, J., Hu, X. & Xu, C. (2009) Elevated expression of IL-12 and IL-23 in patients with aplastic anemia. International Journal of Laboratory Hematology, 31, 207-214.
18. Hara, T., Ando, K., Tsurumi, H. & Moriwaki, H. (2004) Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. European Journal of Haematology, 73, 10-16.
19. Hasan, M., Lopez-Herrera, G., Blomberg, K.E., Lindvall, J.M., Berglof, A., Smith, C.I. & Vargas, L. (2008) Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology, 123, 239-249.
20. Jackson, J.D., Yan, Y., Brunda, M.J., Kelsey, L.S. & Talmadge, J.E. (1995) Interleukin-12 enhances peripheral hematopoiesis in vivo. Blood, 85, 2371-2376.
21. Larousserie, F., Bardel, E., Pflanz, S., Arnulf, B., Lome-Maldonado, C., Hermine, O., Bregeaud, L., Perennec, M., Brousse, N., Kastelein, R. & Devergne, O. (2005) Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. American Journal of Pathology, 166, 1217-1228.
22. Li, J.P., Zheng, C.L. & Han, Z.C. (2010a) Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Critical Reviews in Oncology/hematology, 75, 79-93.
23. Li, T.T., Zhang, T., Chen, G.M., Zhu, Q.Q., Tao, J.H., Pan, H.F. & Ye, D.Q. (2010b) Low level of serum interleukin 27 in patients with systemic lupus erythematosus. Journal of Investigative Medicine, 58, 737-739.
24. Marsh, J.C., Ball, S.E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon-Smith, E.C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., Killick, S.B., Stewart, R. & Yin, J.A. (2009) Guidelines for the diagnosis and management of aplastic anaemia. British Journal Haematology, 147, 43-70.
25. Mayer, K.D., Mohrs, K., Reiley, W., Wittmer, S., Kohlmeier, J.E., Pearl, J.E., Cooper, A.M., Johnson, L.L., Woodland, D.L. & Mohrs, M. (2008) Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. Journal of Immunology, 180, 693-697.
26. Morishima, N., Mizoguchi, I., Okumura, M., Chiba, Y., Xu, M., Shimizu, M., Matsui, M., Mizuguchi, J. & Yoshimoto, T. (2010) A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. Journal of Biomedicine and Biotechnology, 2010, 605483.
27. Neufert, C., Becker, C., Wirtz, S., Fantini, M.C., Weigmann, B., Galle, P.R. & Neurath, M.F. (2007) IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. European Journal of Immunology, 37, 1809-1816.
28. Owaki, T., Asakawa, M., Fukai, F., Mizuguchi, J. & Yoshimoto, T. (2006) IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. Journal of Immunology, 177, 7579-7587.
29. Pflanz, S., Timans, J.C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W.M., Mattson, J.D., Wagner, J.L., To, W., Zurawski, S., McClanahan, T.K., Gorman, D.M., Bazan, J.F., de Waal Malefyt, R., Rennick, D. & Kastelein, R.A. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity, 16, 779-790.
30. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J.F., Phillips, J.H., McClanahan, T.K., de Waal Malefyt, R. & Kastelein, R.A. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. Journal of Immunology, 172, 2225-2231.
31. Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S.C. & Stallmach, A. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflammatory Bowel Diseases, 11, 16-23.
32. Schuetze, N., Schoeneberger, S., Mueller, U., Freudenberg, M.A., Alber, G. & Straubinger, R.K. (2005) IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. International Immunology, 17, 649-659.
33. Schultz, J.C. & Shahidi, N.T. (1994) Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. American Journal of Hematology, 45, 32-38.
34. Seita, J., Asakawa, M., Ooehara, J., Takayanagi, S., Morita, Y., Watanabe, N., Fujita, K., Kudo, M., Mizuguchi, J., Ema, H., Nakauchi, H. & Yoshimoto, T. (2008) Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood, 111, 1903-1912.
35. Sloand, E., Kim, S., Maciejewski, J.P., Tisdale, J., Follmann, D. & Young, N.S. (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood, 100, 1185-1191.
36. Solomou, E.E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A.J. & Young, N.S. (2007) Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood, 110, 1603-1606.
37. Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T.W., Yoshimura, A. & Yoshida, H. (2003) Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. Journal of Immunology, 170, 4886-4890.
38. Troy, A.E., Zaph, C., Du, Y., Taylor, B.C., Guild, K.J., Hunter, C.A., Saris, C.J. & Artis, D. (2009) IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. Journal of Immunology, 183, 2037-2044.
39. Villarino, A.V., Huang, E. & Hunter, C.A. (2004) Understanding the pro- and anti-inflammatory properties of IL-27. Journal of Immunology, 173, 715-720.
40. Weiss, J.M., Subleski, J.J., Wigginton, J.M. & Wiltrout, R.H. (2007) Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opinion on Biological Therapy, 7, 1705-1721.
41. Wirtz, S., Becker, C., Fantini, M.C., Nieuwenhuis, E.E., Tubbe, I., Galle, P.R., Schild, H.J., Birkenbach, M., Blumberg, R.S. & Neurath, M.F. (2005) EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. Journal of Immunology, 174, 2814-2824.
42. Wittmann, M., Zeitvogel, J., Wang, D. & Werfel, T. (2009) IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. Journal of Allergy and Clinical Immunology, 124, 81-89.
43. Wong, C.K., Chen, D.P., Tam, L.S., Li, E.K., Yin, Y.B. & Lam, C.W. (2010) Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research and Therapy, 12, R129.
44. Yoshimoto, T., Morishima, N., Mizoguchi, I., Shimizu, M., Nagai, H., Oniki, S., Oka, M., Nishigori, C. & Mizuguchi, J. (2008) Antiproliferative activity of IL-27 on melanoma. Journal of Immunology, 180, 6527-6535.
45. Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 2509-2519.
46. Zhou, B., Bi, Y.Y., Han, Z.B., Ren, H., Fang, Z.H., Yu, X.F., Poon, M.C. & Han, Z.C. (2006) G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability. Journal of Thrombosis and Haemostasis, 4, 993-1002.
47. Zoumbos, N.C., Gascon, P., Djeu, J.Y. & Young, N.S. (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proceedings of the National Academy of Sciences of the United States of America, 82, 188-192.